HomeASND • NASDAQ
add
Ascendis Pharma A/S
Previous close
$218.10
Day range
$213.02 - $221.80
Year range
$124.06 - $242.00
Market cap
13.41B USD
Avg Volume
734.96K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (EUR) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 247.50M | 42.31% |
Operating expense | 221.51M | 38.87% |
Net income | -33.56M | 12.76% |
Net profit margin | -13.56 | 38.70% |
Earnings per share | -0.55 | 14.06% |
EBITDA | 3.60M | 122.79% |
Effective tax rate | -25.68% | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 616.04M | 10.10% |
Total assets | 1.30B | 10.43% |
Total liabilities | 1.47B | 14.02% |
Total equity | -162.82M | — |
Shares outstanding | 61.38M | — |
Price to book | -82.30 | — |
Return on assets | 0.49% | — |
Return on capital | 0.89% | — |
Cash Flow
Net change in cash
| (EUR) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -33.56M | 12.76% |
Cash from operations | 73.40M | 184.20% |
Cash from investing | -3.39M | -783.07% |
Cash from financing | 8.52M | 9,689.66% |
Net change in cash | 76.95M | 216.64% |
Free cash flow | 50.63M | 148.56% |
About
Founded
2006
Website
Employees
1,189
